Key points are not available for this paper at this time.
These results suggest that DHMEQ can be a potential therapeutic agent for MCNS.
Shimo et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: